Ekso Bionics
EKSO
Ekso Bionics (EKSO) - Cash on Hand
Cash on Hand as of March 2024 : $8.79 M
According to Ekso Bionics
's latest financial reports the company has $8.79 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ekso Bionics - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $8.63 M | -57.91% |
| 2022-12-31 | $20.52 M | -49.2% |
| 2021-12-31 | $40.4 M | 214.15% |
| 2020-12-31 | $12.86 M | 18.3% |
| 2019-12-31 | $10.87 M | 42.02% |
| 2018-12-31 | $7.65 M | -72.48% |
| 2017-12-31 | $27.81 M | 65.1% |
| 2016-12-31 | $16.84 M | -13.84% |
| 2015-12-31 | $19.55 M | -22.38% |
| 2014-12-31 | $25.19 M | |
| 2013-03-31 | $0.02 M | 245.55% |
| 2012-03-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 STAAR Surgical STAA | $0.24 B | 2,686.10% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.26 B | 2,897.75% | 🇺🇸 USA |
 AtriCure ATRC | $0.10 B | 1,104.19% | 🇺🇸 USA |
 Biolase
BIOL | $6.39 M | -27.34% | 🇺🇸 USA |